drug serialisation Rapid implemenation of off-line serialisat...Serialisation of drugs is confronting pharmaceutical companies all over the world with challenges, especially in relation to data handling and the integration of additional equipment and functions into … more ➔
Chromosome IV, Huntingtons disease The hunt for a cure for Huntington’sGenetic Diseases:?Its a disease that often strikes people in the prime of life, slowly destroying control over body, mind and personality. It inevitably kills the patient, but usually only after at … more ➔
Ayoxxa, diabetic retinopathy, Lunaris Insight into biomarkersAYOXXAs LUNARIS platform:?In a case study "Translational proteomics: a new perspective for ophthalmology research, Ayoxxa gives insights into the capabilities of its Lunaris multiplex protein … more ➔
Bright future for biomanufacturersProgress in process engineering and media optimisation has resulted in significant productivity increases in upstream processing driving transformations at drug developers and CDMOs. At BPI Europe in … more ➔
CRISPR & Co.: Brave new foodThe possibilities offered by CRISPR/Cas9, TALENs and other new genome editing technologies are making the mouths of plant breeders water – and not just because the methods give seed developers new options … more ➔
Checkpoint modulation: Blocking the tumour...Belgian, Swiss, and US researchers have found a new way to boost efficacy in cancer immunotherapy. In mid-April, they reported that cancer cells actively block tumour infiltration of cytotoxic T cells, … more ➔
Cleaning up the oceansFrench green chemistry pioneer, Carbios SA (Clermont-Ferrand) announced in March that it has secured equity financing of €2.5m from Kepler Cheuvreux through the acquisition of 380,000 shares over 24 … more ➔
Acquisition: Thermo enters CMO worldLab equipment giant Thermo Fisher Scientific Inc. is growing even bigger. more ➔
Orphan drugs: Treating a raritySince US senators in February conveyed the impression that drug developers might have misused market monopolies related to orphan drugs (ODs) to overprice their compounds, the status has come under closer … more ➔
Allergies: Public Enemy Number OneThe concept has been around for more than a century, but recent advances in the field are causing numerous experts to say its widely underused. The goal of allergen immunotherapy (AIT) is to induce … more ➔
